OPAT / HITH Masterclass 1 - Optimised dosing decisions in OPAT/HITH
Join the first CRE RESPOND OPAT/HITH Masterclass for 2023 to hear expert clinicians and clinical educators discuss Optimised Dosing Decisions, including perspectives on the use of antimicrobial therapeutic drug monitoring (TDM) for paediatric patients; dosing of meropenem in OPAT, challenges and successes of endocarditis in OPAT; and for who, when, where Oritavancin should be used. We look forward to an interesting discussion – join us to ask our panel about your experiences.
CRE RESPOND offers a light dinner to those attending in person at the RBWH Education Centre, Herston, QLD from 5.30pm. A Zoom link will be provided to those attending the seminar online.
We apologise that due to technological fail all of the recordings are not available for this seminar.
Programme:
6.00 pm AEST Welcome and Introduction
Chair and moderator: Prof Jason Roberts, The University of Queensland Director of CRE RESPOND, Brisbane
Co-chair: Dr Eliza Milliken, Herston Infectious Diseases Institute and the Royal Brisbane and Women's Hospital
6.05 pm AEST Antimicrobial TDM in OPAT/HITH for paediatrics: A Queensland perspective
Ms Nicolette Graham, Queensland Children's Hospital
6.25 pm AEST Meropenem use in OPAT: Is there any evidence for dosing?
Dr Stephen Perks, Townsville Hospital and Health Service, Queensland
6.45 pm AEST Endocarditis dosing in OPAT: challenges and successes
Dr Robert Horvath, Prince Charles Hospital, Queensland
7.05 pm AEST Antimicrobial TDM in OPAT/HITH for adults: A Queensland perspective
Dr Adam Stewart, UQ Centre for Clinical Research, Queensland
7.25 pm AEST Questions & Answers
7.45 pm AEST Close
About Outpatient Parenteral Antimicrobial Therapy (OPAT), Hospital in the Home (HITH) Masterclasses
CRE RESPOND continues its educational series on Outpatient Parenteral Antimicrobial Therapy (OPAT) / Hospital in the Home (HITH) Masterclass Series in 2025. Click here to subscribe to CRE RESPOND to receive an invitation.
We are proud to deliver this educational and research capacity-building activity designed to connect the leaders in the field with relevant clinicians, researchers and industry across the country and abroad. OPAT in the context of HITH is increasing in popularity and use globally, and the need for information on practices and principles of its use is evident. Current trends highlight opportunities for further expansion of scope and mechanisms to provide more convenient and cost-effective care.
2025 Masterclass Dates:
- OPAT/HITH Masterclass: Interplay of parenteral and oral antimicrobials in the community, Thursday 19 June 2025
Organising Committee
CRE RESPOND gratefully acknowledges the organisers of the OPAT / HITH Masterclass series for their contribution:
- Dr Fekade Sime, NHMRC Emerging Leadership Fellow, Antimicrobial Optimisation, UQ Centre for Clinical Research
- Associate Professor Benjamin Rogers, Monash Infectious Diseases and Monash Hospital in The Home, Melbourne
- Dr James Pollard, Clinical Director of Community Care, Cabrini Health, Melbourne
- Ms Nicolette Graham, Antimicrobial Stewardship Pharmacist, Queensland Children's Hospital
- Mr Sean Unwin, Infectious Disease Pharmacist, The Princess Alexandra Hospital, Queensland
- Professor Jason Roberts, Director CRE REDUCE, and NHMRC Practitioner Fellow, The University of Queensland
2024 Program Sponsors:
